Turning the page.

Abstract

In 2016, the editorial structure at PCMR will change. I will be stepping down as Co-Editor and Heinz Arnheiter will become Editor-in-Chief. Heinz has been Co-Editor the past 3 years and was Executive Editor for 3 years prior to that. I am certain that the journal is in very good hands under Heinz's experienced leadership. In addition, Georgina Long and John Harris have agreed to join the editorial team as Associate Editors. Andrew Aplin and Robert Kelsh will continue in their current roles of Associate Editor and Review Editor. Marisol Soengas and Lidia Kos also end their terms as Executive Editors. I personally thank Heinz, Robert, Andrew, Marisol, and Lidia for their hard work and efforts as fellow editors of PCMR. I also thank reviewers for their selfless efforts, the pigment cell and melanoma societies that the journal represents, the editorial and production teams at Wiley, and Pernille Hammelsoe and Jackie Jones, our publishers at Wiley. I end my term as Co-Editor with mixed feelings. It has been a great pleasure working with authors, reviewers, the editorial team and Wiley over the past 3 years. This has been a very exciting time for pigment cell and melanoma research. Great strides have been made in pigment cell biology, melanoma genetics and the treatment of melanoma patients. This trend will clearly continue moving forward. While it has always been a pleasure to complete each issue of PCMR, there is a time commitment involved that has been difficult to sustain in the face of competing clinical, scientific and academic obligations. After my term of service, I have a much greater appreciation of the herculean efforts of former Editors of PCMR, including Colin Goding and Ze'ev Ronai. In the editing process, a balance needs to be struck between attempting to be fair in all decisions and pushing to make the impact of the journal as high as possible. This includes making decisions about the novelty and potential impact of submitted manuscripts. As the number of high-quality manuscripts goes up, the acceptance rate invariably goes down, which means that pigment cell and melanoma researchers are obligated to find other places to publish some of their work that did not make the cut. On the other hand, submission of the most impactful and novel manuscripts is the single most important factor that increases the impact and relevance of the journal. Please continue submitting top manuscripts to PCMR!